WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt
Suicide, Attempted, Suicidal Ideation, Depression
About this trial
This is an interventional prevention trial for Suicide, Attempted focused on measuring Older Adults, Middle Aged Adults
Eligibility Criteria
Inclusion Criteria:
- 50-90 years old
- Diagnosis (based on a modified SCID-5 Clinical Trials Version to assess DSM-5 diagnoses): Any DSM-5 except: current diagnosis of Psychotic Disorder; diagnosis of Dementia
- Recent hospitalization for suicidal ideation or suicide attempt; at hospital admission, Columbia Suicide Severity Rating Scale (CSSR-S) ≥ 2, "Non-specific Active Suicidal Thoughts."
- We will also include patients on psychotropics and on after-care community psychotherapy.
Exclusion Criteria:
- Current diagnosis of Psychotic Disorders; Diagnosis of Dementia
- Cognitive Impairment (MMSE ≤ 24)
- Acute or severe medical illness (i.e., delirium; decompensated cardiac, liver or kidney failure; major surgery; stroke or myocardial infarction during the three months prior to entry
- Aphasia, sensory problems, and/or inability to speak English.
Sites / Locations
- New York Presbyterian Hospital/Weill Cornell Medicine
- Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell MedicineRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
No Intervention
Proof-of-Concept WellPATH-PREVENT (R61)
Optimized WellPATH-PREVENT (R33)
Attention Control Usual Care (R33)
The AC-UC group will parallel the delivery of the WellPATH-PREVENT intervention and will also include: a) meetings during hospitalization: a non-clinical member of the team will present the control tablet and explain its use; b) scheduled or requested meetings through zoom: to parallel the delivery of WellPATH-PREVENT. The tablet will still have a link to schedule a meeting with a non-clinician member of the team. The meetings will focus on issues that the patient may have in using the tablet. There will not be any therapeutic or psychological interaction between participants in the control group and the team. The experimental and the control group will also be under usual outpatient care, which is arranged during the hospitalization by the inpatient treatment team.